MARKET

SRPT

SRPT

Sarepta Therapeutics Inc
NASDAQ
119.98
-1.40
-1.15%
After Hours: 120.25 +0.27 +0.23% 19:59 06/12 EDT
OPEN
122.93
PREV CLOSE
121.38
HIGH
123.53
LOW
118.70
VOLUME
701.72K
TURNOVER
0
52 WEEK HIGH
146.68
52 WEEK LOW
55.25
MARKET CAP
11.34B
P/E (TTM)
1505.40
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at SRPT last week (0603-0607)?
Weekly Report · 3d ago
Sarepta Therapeutics Expands Incentive Plan, Shareholders Vote
TipRanks · 5d ago
Weekly Report: what happened at SRPT last week (0527-0531)?
Weekly Report · 06/03 09:21
SAREPTA THERAPEUTICS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)
Reuters · 05/31 21:45
Interesting SRPT Put Options For July 12th
NASDAQ · 05/31 15:58
Sarepta Therapeutics Initiated at Overweight by Piper Sandler
Dow Jones · 05/31 10:10
Sarepta Therapeutics Price Target Announced at $157.00/Share by Piper Sandler
Dow Jones · 05/31 10:10
Positive Outlook for Sarepta Therapeutics Amidst PDUFA Date and Regulatory Support
TipRanks · 05/31 09:58
More
About SRPT
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on helping patients through the discovery and development of ribonucleic acid (RNA)-targeted therapeutics, gene therapy and other genetic therapeutic modalities for the treatment of rare diseases. It has developed multiple approved products for the treatment of Duchenne muscular dystrophy (Duchenne) and is developing potential therapeutic candidates for a range of diseases and disorders, including Duchenne, Limb-girdle muscular dystrophies (LGMDs) and other neuromuscular and central nervous system (CNS) related disorders. It has developed and commercialized four approved products for the treatment of Duchenne: EXONDYS 51 (eteplirsen), Injection (EXONDYS 51), VYONDYS 53 (golodirsen) Injection (VYONDYS 53), AMONDYS 45 (casimersen) Injection (AMONDYS 45), and ELEVIDYS. Its pipeline includes approximately 40 programs at various stages of discovery, pre-clinical and clinical development.

Webull offers Sarepta Therapeutics Inc stock information, including NASDAQ: SRPT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SRPT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SRPT stock methods without spending real money on the virtual paper trading platform.